Therapeutic targets for neuroprotection and/or enhancement of functional recovery following traumatic brain injury

Progress in Molecular Biology and Translational Science

Volumn 98, Issue C, 2011, Pages 85-131

  Kelso, Matthew L ^a   Pauly, James R ^b,c  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b University of Kentucky   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Clinical; Preclinical; Primary injury; Secondary injury

Indexed keywords

EID: 78650896188     PISSN: 18771173     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-385506-0.00003-X     Document Type: Chapter

References (286)

1. M. Faul, L. Xu, M.M. Wald, and V.G. Coronado Traumatic brain injury in the United States: Emergency Department Visits, Hospitalizations and Deaths 2002-2006 2010 Centers for Disease Control and Prevention National Center for Injury Prevention and Control, Atlanta, GA
2. D.J. Thurman The epidemiology and economics of head trauma L.P. Miller, R.L. Hayes, Head trauma: basic, preclinical, and clinical directions 2001 Wiley-Liss New York 327 347
3. M. Schootman, T.G. Buchman, and L.M. Lewis National estimates of hospitalization charges for the acute care of traumatic brain injuries Brain Inj 17 2003 983 990
4. L.J. McGarry, D. Thompson, F.H. Millham, L. Cowell, P.J. Snyder, and W.R. Lenderking Outcomes and costs of acute treatment of traumatic brain injury J Trauma 53 2002 1152 1159
5. M. Faul, M.M. Wald, W. Rutland-Brown, E.E. Sullivent, and R.W. Sattin Using a cost-benefit analysis to estimate outcomes of a clinical treatment guideline: testing the Brain Trauma Foundation guidelines for the treatment of severe traumatic brain injury J Trauma 63 2007 1271 1278
6. C.M. Cameron, D.M. Purdie, E.V. Kliewer, and R.J. McClure Ten-year outcomes following traumatic brain injury: a population-based cohort Brain Inj 22 2008 437 449
7. N.H. Mayer, J. Pelensky, J. Whyte, and R. Fidler-Sheppard Characterization and correlates of medical and rehabilitation charges for traumatic brain injury during acute rehabilitation hospitalization Arch Phys Med Rehabil 84 2003 242 248
8. D. Thurman, and J. Guerrero Trends in hospitalization associated with traumatic brain injury Jama 282 1999 954 957 (Pubitemid 29420314)
9. Consensus conference. Rehabilitation of persons with traumatic brain injury. NIH Consensus Development Panel on Rehabilitation of Persons With Traumatic Brain Injury Jama 282 1999 974 983
10. D.J. Thurman, C. Alverson, K.A. Dunn, J. Guerrero, and J.E. Sniezek Traumatic brain injury in the United States: a public health perspective J Head Trauma Rehabil 14 1999 602 615
11. National Institute of Neurological Disorders and Stroke Traumatic brain injury: hope through research 2002 National Institute of Health Bethesda, MD
12. T.W. Teasdale, and A.W. Engberg Subjective well-being and quality of life following traumatic brain injury in adults: a long-term population-based follow-up Brain Inj 19 2005 1041 1048
13. K.D. Cicerone, and J. Azulay Perceived self-efficacy and life satisfaction after traumatic brain injury J Head Trauma Rehabil 22 2007 257 266
14. A. Serino, E. Ciaramelli, A. Di Santantonio, S. Malagu, F. Servadei, and E. Ladavas Central executive system impairment in traumatic brain injury Brain Inj 20 2006 23 32
15. C. Sadowski-Cron, J. Schneider, P. Senn, B.P. Radanov, P. Ballinari, and H. Zimmermann Patients with mild traumatic brain injury: immediate and long-term outcome compared to intra-cranial injuries on CT scan Brain Inj 20 2006 1131 1137
16. C.W. Hoge, D. McGurk, J.L. Thomas, A.L. Cox, C.C. Engel, and C.A. Castro Mild traumatic brain injury in U.S. Soldiers returning from Iraq N Engl J Med 358 2008 453 463
17. S.P. Broglio, S.N. Macciocchi, and M.S. Ferrara Neurocognitive performance of concussed athletes when symptom free J Athl Train 42 2007 504 508
18. D.L. Warden, B. Gordon, T.W. McAllister, J.M. Silver, J.T. Barth, and J. Bruns Guidelines for the pharmacologic treatment of neurobehavioral sequelae of traumatic brain injury J Neurotrauma 23 2006 1468 1501
19. T.W. Vitaz, J. Jenks, G.H. Raque, and C.B. Shields Outcome following moderate traumatic brain injury Surg Neurol 60 2003 285 291 discussion 291
20. J.D. Corrigan, G. Whiteneck, and D. Mellick Perceived needs following traumatic brain injury J Head Trauma Rehabil 19 2004 205 216 (Pubitemid 38703119)
21. R.K. Narayan, M.E. Michel, B. Ansell, A. Baethmann, A. Biegon, and M.B. Bracken Clinical trials in head injury J Neurotrauma 19 2002 503 557
22. C. Ikonomidou, and L. Turski Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury? Lancet Neurol 1 2002 383 386
23. S. Margulies, and R. Hicks Combination therapies for traumatic brain injury: prospective considerations J Neurotrauma 26 2009 925 939
24. K.E. Saatman, A.C. Duhaime, R. Bullock, A.I. Maas, A. Valadka, and G.T. Manley Classification of traumatic brain injury for targeted therapies J Neurotrauma 25 2008 719 738
25. A.L. Halliday Pathophysiology D.W. Marion, Traumatic brain injury 1999 Thieme New York 29 38
26. D.M. Morales, N. Marklund, D. Lebold, H.J. Thompson, A. Pitkanen, and W.L. Maxwell Experimental models of traumatic brain injury: do we really need to build a better mousetrap? Neuroscience 136 2005 971 989
27. T.A. Gennarelli Mechanisms of brain injury J Emerg Med 11 Suppl. 1 1993 5 11
28. M. Gaetz The neurophysiology of brain injury Clin Neurophysiol 115 2004 4 18
29. I. Cernak Animal models of head trauma NeuroRx 2 2005 410 422
30. J.W. Lighthall Controlled cortical impact: a new experimental brain injury model J Neurotrauma 5 1988 1 15
31. C.E. Dixon, G.L. Clifton, J.W. Lighthall, A.A. Yaghmai, and R.L. Hayes A controlled cortical impact model of traumatic brain injury in the rat J Neurosci Methods 39 1991 253 262
32. D.H. Smith, H.D. Soares, J.S. Pierce, K.G. Perlman, K.E. Saatman, and D.F. Meaney A model of parasagittal controlled cortical impact in the mouse: cognitive and histopathologic effects J Neurotrauma 12 1995 169 178
33. G.L. Collingridge The induction of N-methyl-D-aspartate receptor-dependent long-term potentiation Philos Trans R Soc Lond B Biol Sci 358 2003 635 641
34. E. Miyamoto Molecular mechanism of neuronal plasticity: induction and maintenance of long-term potentiation in the hippocampus J Pharmacol Sci 100 2006 433 442
35. R.G. Morris Long-term potentiation and memory Philos Trans R Soc Lond B Biol Sci 358 2003 643 647
36. R. Bullock, A. Zauner, J.J. Woodward, J. Myseros, S.C. Choi, and J.D. Ward Factors affecting excitatory amino acid release following severe human head injury J Neurosurg 89 1998 507 518 (Pubitemid 28440917)
37. A.M. Palmer, D.W. Marion, M.L. Botscheller, D.M. Bowen, and S.T. DeKosky Increased transmitter amino acid concentration in human ventricular CSF after brain trauma NeuroReport 6 1994 153 156
38. A.J. Baker, R.J. Moulton, V.H. MacMillan, and P.M. Shedden Excitatory amino acids in cerebrospinal fluid following traumatic brain injury in humans J Neurosurg 79 1993 369 372
39. H. Zhang, X. Zhang, T. Zhang, and L. Chen Excitatory amino acids in cerebrospinal fluid of patients with acute head injuries Clin Chem 47 2001 1458 1462
40. M.A. Seifman, A.A. Adamides, P.N. Nguyen, S.A. Vallance, D.J. Cooper, and T. Kossmann Endogenous melatonin increases in cerebrospinal fluid of patients after severe traumatic brain injury and correlates with oxidative stress and metabolic disarray J Cereb Blood Flow Metab 28 2008 684 696
41. J.I. Brown, A.J. Baker, S.J. Konasiewicz, and R.J. Moulton Clinical significance of CSF glutamate concentrations following severe traumatic brain injury in humans J Neurotrauma 15 1998 253 263
42. A.I. Faden, P. Demediuk, S.S. Panter, and R. Vink The role of excitatory amino acids and NMDA receptors in traumatic brain injury Science 244 1989 798 800
43. A.M. Palmer, D.W. Marion, M.L. Botscheller, P.E. Swedlow, S.D. Styren, and S.T. DeKosky Traumatic brain injury-induced excitotoxicity assessed in a controlled cortical impact model J Neurochem 61 1993 2015 2024
44. M.E. Rose, M.B. Huerbin, J. Melick, D.W. Marion, A.M. Palmer, and J.K. Schiding Regulation of interstitial excitatory amino acid concentrations after cortical contusion injury Brain Res 935 2002 40 46 (Pubitemid 34327843)
45. J.M. Hinzman, T.C. Thomas, J.J. Burmeister, J.E. Quintero, P. Huettl, and F. Pomerleau Diffuse brain injury elevates tonic glutamate levels and potassium-evoked glutamate release in discrete brain regions at two days post-injury: an enzyme-based microelectrode array study J Neurotrauma 27 2010 889 899
46. F.K. van Landeghem, J.F. Stover, I. Bechmann, W. Bruck, A. Unterberg, and C. Buhrer Early expression of glutamate transporter proteins in ramified microglia after controlled cortical impact injury in the rat Glia 35 2001 167 179
47. C.L. Osteen, C.C. Giza, and D.A. Hovda Injury-induced alterations in N-methyl-D-aspartate receptor subunit composition contribute to prolonged 45calcium accumulation following lateral fluid percussion Neuroscience 128 2004 305 322
48. M.N. DeRidder, M.J. Simon, R. Siman, Y.P. Auberson, R. Raghupathi, and D.F. Meaney Traumatic mechanical injury to the hippocampus in vitro causes regional caspase-3 and calpain activation that is influenced by NMDA receptor subunit composition Neurobiol Dis 22 2006 165 176
49. J. Schumann, G.A. Alexandrovich, A. Biegon, and R. Yaka Inhibition of NR2B phosphorylation restores alterations in NMDA receptor expression and improves functional recovery following traumatic brain injury in mice J Neurotrauma 25 2008 945 957
50. A. Biegon, P.A. Fry, C.M. Paden, A. Alexandrovich, J. Tsenter, and E. Shohami Dynamic changes in N-methyl-D-aspartate receptors after closed head injury in mice: implications for treatment of neurological and cognitive deficits Proc Natl Acad Sci USA 101 2004 5117 5122
51. S.L. Verbois, S.W. Scheff, and J.R. Pauly Time-dependent changes in rat brain cholinergic receptor expression after experimental brain injury J Neurotrauma 19 2002 1569 1585
52. W.F. Hood, R.P. Compton, and J.B. Monahan D-cycloserine: a ligand for the N-methyl-D-aspartate coupled glycine receptor has partial agonist characteristics Neurosci Lett 98 1989 91 95
53. G. Henderson, J.W. Johnson, and P. Ascher Competitive antagonists and partial agonists at the glycine modulatory site of the mouse N-methyl-D-aspartate receptor J Physiol 430 1990 189 212
54. A. Adeleye, E. Shohami, D. Nachman, A. Alexandrovich, V. Trembovler, and R. Yaka D-cycloserine improves functional outcome after traumatic brain injury with wide therapeutic window Eur J Pharmacol 629 2010 25 30
55. S.W. Scheff, S.A. Baldwin, R.W. Brown, and P.J. Kraemer Morris water maze deficits in rats following traumatic brain injury: lateral controlled cortical impact J Neurotrauma 14 1997 615 627
56. C.E. Dixon, S.J. Liu, L.W. Jenkins, M. Bhattachargee, J.S. Whitson, and K. Yang Time course of increased vulnerability of cholinergic neurotransmission following traumatic brain injury in the rat Behav Brain Res 70 1995 125 131
57. L.S. Deshpande, D.A. Sun, S. Sombati, A. Baranova, M.S. Wilson, and E. Attkisson Alterations in neuronal calcium levels are associated with cognitive deficits after traumatic brain injury Neurosci Lett 441 2008 115 119
58. J.M. Spaethling, D.M. Klein, P. Singh, and D.F. Meaney Calcium-permeable AMPA receptors appear in cortical neurons after traumatic mechanical injury and contribute to neuronal fate J Neurotrauma 25 2008 1207 1216
59. P.B. Goforth, E.F. Ellis, and L.S. Satin Mechanical injury modulates AMPA receptor kinetics via an NMDA receptor-dependent pathway J Neurotrauma 21 2004 719 732
60. P.B. Goforth, E.F. Ellis, and L.S. Satin Enhancement of AMPA-mediated current after traumatic injury in cortical neurons J Neurosci 19 1999 7367 7374
61. T. Furukawa, S. Hoshino, S. Kobayashi, T. Asakura, M. Takahashi, and T. Atsumi The glutamate AMPA receptor antagonist, YM872, attenuates cortical tissue loss, regional cerebral edema, and neurological motor deficits after experimental brain injury in rats J Neurotrauma 20 2003 269 278
62. T. Atsumi, S. Hoshino, T. Furukawa, S. Kobayashi, T. Asakura, and M. Takahashi The glutamate AMPA receptor antagonist, YM872, attenuates regional cerebral edema and IgG immunoreactivity following experimental brain injury in rats Acta Neurochir Suppl 86 2003 305 307
63. L. Belayev, O.F. Alonso, Y. Liu, A.S. Chappell, W. Zhao, and M.D. Ginsberg Talampanel, a novel noncompetitive AMPA antagonist, is neuroprotective after traumatic brain injury in rats J Neurotrauma 18 2001 1031 1038
64. A.C. Arai, and M. Kessler Pharmacology of ampakine modulators: from AMPA receptors to synapses and behavior Curr Drug Targets 8 2007 583 602
65. E. Hamlyn, L. Brand, M. Shahid, and B.H. Harvey The ampakine, Org 26576, bolsters early spatial reference learning and retrieval in the Morris water maze: a subchronic, dose-ranging study in rats Behav Pharmacol 20 2009 662 667
66. E. Wezenberg, R.J. Verkes, G.S. Ruigt, W. Hulstijn, and B.G. Sabbe Acute effects of the ampakine farampator on memory and information processing in healthy elderly volunteers Neuropsychopharmacology 32 2007 1272 1283
67. M.E. Hasselmo The role of acetylcholine in learning and memory Curr Opin Neurobiol 16 2006 710 715
68. E.D. Levin Nicotinic receptor subtypes and cognitive function J Neurobiol 53 2002 633 640
69. E.D. Levin, F.J. McClernon, and A.H. Rezvani Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization Psychopharmacology (Berl) 184 2005 1 17
70. B.R. Pike, and R.J. Hamm Post-injury administration of BIBN 99, a selective muscarinic M2 receptor antagonist, improves cognitive performance following traumatic brain injury in rats Brain Res 686 1995 37 43
71. B.G. Lyeth, J.Y. Jiang, T.M. Delahunty, L.L. Phillips, and R.J. Hamm Muscarinic cholinergic receptor binding in rat brain following traumatic brain injury Brain Res 640 1994 240 245
72. J.Y. Jiang, B.G. Lyeth, T.M. Delahunty, L.L. Phillips, and R.J. Hamm Muscarinic cholinergic receptor binding in rat brain at 15 days following traumatic brain injury Brain Res 651 1994 123 128
73. M.M. DeAngelis, R.L. Hayes, and B.G. Lyeth Traumatic brain injury causes a decrease in M2 muscarinic cholinergic receptor binding in the rat brain Brain Res 653 1994 39 44
74. S.L. Verbois, P.G. Sullivan, S.W. Scheff, and J.R. Pauly Traumatic brain injury reduces hippocampal alpha7 nicotinic cholinergic receptor binding J Neurotrauma 17 2000 1001 1011
75. E. Tribollet, D. Bertrand, A. Marguerat, and M. Raggenbass Comparative distribution of nicotinic receptor subtypes during development, adulthood and aging: an autoradiographic study in the rat brain Neuroscience 124 2004 405 420
76. M. Zoli, C. Lena, M.R. Picciotto, and J.P. Changeux Identification of four classes of brain nicotinic receptors using beta2 mutant mice J Neurosci 18 1998 4461 4472
77. 125 I]-alpha-bungarotoxin binding in human postmortem brain J Comp Neurol 387 1997 385 398
78. P. Whiteaker, A.R. Davies, M.J. Marks, I.S. Blagbrough, B.V. Potter, and A.J. Wolstenholme An autoradiographic study of the distribution of binding sites for the novel alpha7-selective nicotinic radioligand [3H]-methyllycaconitine in the mouse brain Eur J Neurosci 11 1999 2689 2696
79. P. Seguela, J. Wadiche, K. Dineley-Miller, J.A. Dani, and J.W. Patrick Molecular cloning, functional properties, and distribution of rat brain alpha 7: a nicotinic cation channel highly permeable to calcium J Neurosci 13 1993 596 604
80. 2+ permeability of nicotinic acetylcholine receptors Cell Calcium 35 2004 1 8
81. 2+ regulation of nicotinic acetylcholine receptor channels in rat hippocampal CA1 neurons J Neurosci 23 2003 9024 9031
82. O. Delbono, M. Gopalakrishnan, M. Renganathan, L.M. Monteggia, M.L. Messi, and J.P. Sullivan Activation of the recombinant human alpha 7 nicotinic acetylcholine receptor significantly raises intracellular free calcium J Pharmacol Exp Ther 280 1997 428 438
83. A. Mike, N.G. Castro, and E.X. Albuquerque Choline and acetylcholine have similar kinetic properties of activation and desensitization on the alpha7 nicotinic receptors in rat hippocampal neurons Brain Res 882 2000 155 168
84. M.W. Quick, and R.A. Lester Desensitization of neuronal nicotinic receptors J Neurobiol 53 2002 457 478
85. S.L. Verbois, S.W. Scheff, and J.R. Pauly Chronic nicotine treatment attenuates alpha 7 nicotinic receptor deficits following traumatic brain injury Neuropharmacology 44 2003 224 233
86. S.L. Verbois, D.M. Hopkins, S.W. Scheff, and J.R. Pauly Chronic intermittent nicotine administration attenuates traumatic brain injury-induced cognitive dysfunction Neuroscience 119 2003 1199 1208
87. M.L. Kelso, J.M. Wehner, A.C. Collins, S.W. Scheff, and J.R. Pauly The pathophysiology of traumatic brain injury in alpha7 nicotinic cholinergic receptor knockout mice Brain Res 1083 2006 204 210
88. J. Hannon, and D. Hoyer Molecular biology of 5-HT receptors Behav Brain Res 195 2008 198 213
89. R. Busto, W.D. Dietrich, M.Y. Globus, O. Alonso, and M.D. Ginsberg Extracellular release of serotonin following fluid-percussion brain injury in rats J Neurotrauma 14 1997 35 42
90. T.J. Turner, D.J. Mokler, and J.I. Luebke Calcium influx through presynaptic 5-HT3 receptors facilitates GABA release in the hippocampus: in vitro slice and synaptosome studies Neuroscience 129 2004 703 718
91. R.L. Papke, H.C. Schiff, B.A. Jack, and N.A. Horenstein Molecular dissection of tropisetron, an alpha7 nicotinic acetylcholine receptor-selective partial agonist Neurosci Lett 378 2005 140 144
92. E. Candelario-Jalil, E. Munoz, and B.L. Fiebich Detrimental effects of tropisetron on permanent ischemic stroke in the rat BMC Neurosci 9 2008 19
93. R.W. Olsen, and W. Sieghart International Union of Pharmacology. LXX. Subtypes of gamma-aminobutyric acid(A) receptors: classification on the basis of subunit composition, pharmacology, and function. Update Pharmacol Rev 60 2008 243 260
94. C.J. Gibson, R.C. Meyer, and R.J. Hamm Traumatic brain injury and the effects of diazepam, diltiazem, and MK-801 on GABA-A receptor subunit expression in rat hippocampus J Biomed Sci 17 2010 38
95. Z. Mtchedlishvili, E. Lepsveridze, H. Xu, E.A. Kharlamov, B. Lu, and K.M. Kelly Increase of GABAA receptor-mediated tonic inhibition in dentate granule cells after traumatic brain injury Neurobiol Dis 38 2010 464 475
96. P.G. Ochalski, W. Fellows-Mayle, L.B. Hsieh, R. Srinivas, D.O. Okonkwo, and C.E. Dixon Flumazenil administration attenuates cognitive impairment in immature rats after controlled cortical impact J Neurotrauma 27 2010 647 651
97. NINDS Spasticity Information Page [Internet] Bethesda MD: National Institutes of Health, National Institute of Neurological Disorders and Stroke, Office of Communications and Public Liason; [Updated 06/25/2010]; http://www.ninds.nih.gov/disorders/spasticity/spasticity.htm
98. S. Marshall, R. Teasell, N. Bayona, C. Lippert, J. Chundamala, and J. Villamere Motor impairment rehabilitation post acquired brain injury Brain Inj 21 2007 133 160 (Pubitemid 46443630)
99. K.A. Helm, R.P. Haberman, S.L. Dean, E.C. Hoyt, T. Melcher, and P.K. Lund GABAB receptor antagonist SGS742 improves spatial memory and reduces protein binding to the cAMP response element (CRE) in the hippocampus Neuropharmacology 48 2005 956 964
100. R. Bullock SGS-742 Novartis Curr Opin Investig Drugs 6 2005 108 113
101. I. Fineman, D.A. Hovda, M. Smith, A. Yoshino, and D.P. Becker Concussive brain injury is associated with a prolonged accumulation of calcium: a 45Ca autoradiographic study Brain Res 624 1993 94 102
102. P. Nilsson, H. Laursen, L. Hillered, and A.J. Hansen Calcium movements in traumatic brain injury: the role of glutamate receptor-operated ion channels J Cereb Blood Flow Metab 16 1996 262 270
103. 2+ homeostatic mechanisms in hippocampal neurons surviving brain injury Eur J Neurosci 27 2008 1659 1672
104. M.P. Mattson Calcium and neurodegeneration Aging Cell 6 2007 337 350
105. I.N. Singh, P.G. Sullivan, Y. Deng, L.H. Mbye, and E.D. Hall Time course of post-traumatic mitochondrial oxidative damage and dysfunction in a mouse model of focal traumatic brain injury: implications for neuroprotective therapy J Cereb Blood Flow Metab 26 2006 1407 1418
106. J. Langham, C. Goldfrad, G. Teasdale, D. Shaw, and K. Rowan Calcium channel blockers for acute traumatic brain injury Cochrane Database Syst Rev Issue 4 2003 Art No. CD000565
107. M.D. Vergouwen, M. Vermeulen, and Y.B. Roos Effect of nimodipine on outcome in patients with traumatic subarachnoid haemorrhage: a systematic review Lancet Neurol 5 2006 1029 1032
108. A. Aslan, M. Gurelik, M. Cemek, H.M. Goksel, and M.E. Buyukokuroglu Nimodipine can improve cerebral metabolism and outcome in patients with severe head trauma Pharmacol Res 59 2009 120 124
109. D.J. Lee, P. Moftakhar, T.C. Glenn, P.M. Vespa, and N.A. Martin Intra-arterial calcium channel blocker infusion for treatment of severe vasospasm in traumatic brain injury: case report Neurosurgery 63 2008 E1004 E1006 discussion E1006
110. K.R. Byrnes, D.J. Loane, and A.I. Faden Metabotropic glutamate receptors as targets for multipotential treatment of neurological disorders Neurotherapeutics 6 2009 94 107
111. Q.Z. Gong, T.M. Delahunty, R.J. Hamm, and B.G. Lyeth Metabotropic glutamate antagonist, MCPG, treatment of traumatic brain injury in rats Brain Res 700 1995 299 302
112. A. Mukhin, L. Fan, and A.I. Faden Activation of metabotropic glutamate receptor subtype mGluR1 contributes to post-traumatic neuronal injury J Neurosci 16 1996 6012 6020
113. J.W. Allen, S.A. Ivanova, L. Fan, M.G. Espey, A.S. Basile, and A.I. Faden Group II metabotropic glutamate receptor activation attenuates traumatic neuronal injury and improves neurological recovery after traumatic brain injury J Pharmacol Exp Ther 290 1999 112 120
114. A.I. Faden, S.A. Ivanova, A.G. Yakovlev, and A.G. Mukhin Neuroprotective effects of group III mGluR in traumatic neuronal injury J Neurotrauma 14 1997 885 895
115. C. Missale, S.R. Nash, S.W. Robinson, M. Jaber, and M.G. Caron Dopamine receptors: from structure to function Physiol Rev 78 1998 189 225
116. J.L. Massucci, A.E. Kline, X. Ma, R.D. Zafonte, and C.E. Dixon Time dependent alterations in dopamine tissue levels and metabolism after experimental traumatic brain injury in rats Neurosci Lett 372 2004 127 131
117. A.K. Wagner, J.E. Sokoloski, D. Ren, X. Chen, A.S. Khan, and R.D. Zafonte Controlled cortical impact injury affects dopaminergic transmission in the rat striatum J Neurochem 95 2005 457 465 (Pubitemid 41457514)
118. N. Kobori, G.L. Clifton, and P.K. Dash Enhanced catecholamine synthesis in the prefrontal cortex after traumatic brain injury: implications for prefrontal dysfunction J Neurotrauma 23 2006 1094 1102
119. H.Q. Yan, X. Ma, X. Chen, Y. Li, L. Shao, and C.E. Dixon Delayed increase of tyrosine hydroxylase expression in rat nigrostriatal system after traumatic brain injury Brain Res 1134 2007 171 179
120. J.W. Bales, A.K. Wagner, A.E. Kline, and C.E. Dixon Persistent cognitive dysfunction after traumatic brain injury: a dopamine hypothesis Neurosci Biobehav Rev 33 2009 981 1003
121. J.P. Genro, C. Kieling, L.A. Rohde, and M.H. Hutz Attention-deficit/ hyperactivity disorder and the dopaminergic hypotheses Expert Rev Neurother 10 2010 587 601
122. L. Saenz del Burgo, R. Cortes, G. Mengod, J. Zarate, E. Echevarria, and J. Salles Distribution and neurochemical characterization of neurons expressing GIRK channels in the rat brain J Comp Neurol 510 2008 581 606
123. M.U. Ehrengruber, C.A. Doupnik, Y. Xu, J. Garvey, M.C. Jasek, and H.A. Lester Activation of heteromeric G protein-gated inward rectifier K+ channels overexpressed by adenovirus gene transfer inhibits the excitability of hippocampal neurons Proc Natl Acad Sci USA 94 1997 7070 7075
124. A.E. Kline, J. Yu, E. Horvath, D.W. Marion, and C.E. Dixon The selective 5-HT(1A) receptor agonist repinotan HCl attenuates histopathology and spatial learning deficits following traumatic brain injury in rats Neuroscience 106 2001 547 555
125. J.P. Cheng, H.A. Aslam, A.N. Hoffman, R.D. Zafonte, and A.E. Kline The neurobehavioral benefit conferred by a single systemic administration of 8-OH-DPAT after brain trauma is confined to a narrow therapeutic window Neurosci Lett 416 2007 165 168
126. M.S. Wilson, and R.J. Hamm Effects of fluoxetine on the 5-HT1A receptor and recovery of cognitive function after traumatic brain injury in rats Am J Phys Med Rehabil 81 2002 364 372
127. J.P. Cheng, A.N. Hoffman, R.D. Zafonte, and A.E. Kline A delayed and chronic treatment regimen with the 5-HT1A receptor agonist 8-OH-DPAT after cortical impact injury facilitates motor recovery and acquisition of spatial learning Behav Brain Res 194 2008 79 85
128. J.R. Fann, T. Hart, and K.G. Schomer Treatment for depression after traumatic brain injury: a systematic review J Neurotrauma 26 2009 2383 2402
129. D.B. Arciniegas, and T.W. McAllister Neurobehavioral management of traumatic brain injury in the critical care setting Crit Care Clin 24 2008 737 765
130. S.L. Bratton, R.M. Chestnut, J. Ghajar, F.F. McConnell Hammond, O.A. Harris, and R. Hartl Guidelines for the management of severe traumatic brain injury. XI. Anesthetics, analgesics, and sedatives J Neurotrauma 24 Suppl. 1 2007 S71 S76
131. K.D. Statler, H. Alexander, V. Vagni, C.E. Dixon, R.S. Clark, and L. Jenkins Comparison of seven anesthetic agents on outcome after experimental traumatic brain injury in adult, male rats J Neurotrauma 23 2006 97 108
132. O. Zohar, V. Getslev, A.L. Miller, S. Schreiber, and C.G. Pick Morphine protects for head trauma induced cognitive deficits in mice Neurosci Lett 394 2006 239 242
133. D.J. Roberts, K.B. Goralski, K.W. Renton, L.C. Julien, A.M. Webber, and L. Sleno Effect of acute inflammatory brain injury on accumulation of morphine and morphine 3- and 6-glucuronide in the human brain Crit Care Med 37 2009 2767 2774
134. A.N. Hata, and R.M. Breyer Pharmacology and signaling of prostaglandin receptors: multiple roles in inflammation and immune modulation Pharmacol Ther 103 2004 147 166
135. E. Candelario-Jalil, H. Slawik, I. Ridelis, A. Waschbisch, R.S. Akundi, and M. Hull Regional distribution of the prostaglandin E2 receptor EP1 in the rat brain: accumulation in Purkinje cells of the cerebellum J Mol Neurosci 27 2005 303 310
136. T. Kawano, J. Anrather, P. Zhou, L. Park, G. Wang, and K.A. Frys Prostaglandin E2 EP1 receptors: downstream effectors of COX-2 neurotoxicity Nat Med 12 2006 225 229
137. P. Zhou, L. Qian, T. Chou, and C. Iadecola Neuroprotection by PGE2 receptor EP1 inhibition involves the PTEN/AKT pathway Neurobiol Dis 29 2008 543 551
138. K.I. Fukumoto, N. Takagi, R. Yamamoto, Y. Moriyama, S. Takeo, and K. Tanonaka Prostanoid EP(1) receptor antagonist reduces blood-brain barrier leakage after cerebral ischemia Eur J Pharmacol 640 2010 82 86
139. N.G. Carlson, M.A. Rojas, J.D. Black, J.W. Redd, J. Hille, and K.E. Hill Microglial inhibition of neuroprotection by antagonists of the EP1 prostaglandin E2 receptor J Neuroinflammation 6 2009 5
140. L. McCullough, L. Wu, N. Haughey, X. Liang, T. Hand, and Q. Wang Neuroprotective function of the PGE2 EP2 receptor in cerebral ischemia J Neurosci 24 2004 257 268
141. A.O. Caggiano, and R.P. Kraig Prostaglandin E receptor subtypes in cultured rat microglia and their role in reducing lipopolysaccharide-induced interleukin-1beta production J Neurochem 72 1999 565 575
142. R.E. Hulse, W.G. Swenson, P.E. Kunkler, D.M. White, and R.P. Kraig Monomeric IgG is neuroprotective via enhancing microglial recycling endocytosis and TNF-alpha J Neurosci 28 2008 12199 12211
143. F.S. Shie, K.S. Montine, R.M. Breyer, and T.J. Montine Microglial EP2 is critical to neurotoxicity from activated cerebral innate immunity Glia 52 2005 70 77
144. A.S. Ahmad, H. Zhuang, V. Echeverria, and S. Dore Stimulation of prostaglandin EP2 receptors prevents NMDA-induced excitotoxicity J Neurotrauma 23 2006 1895 1903
145. J. Jiang, T. Ganesh, Y. Du, P. Thepchatri, A. Rojas, and I. Lewis Neuroprotection by selective allosteric potentiators of the EP2 prostaglandin receptor Proc Natl Acad Sci USA 107 2010 2307 2312
146. M. Ek, C. Arias, P. Sawchenko, and A. Ericsson-Dahlstrand Distribution of the EP3 prostaglandin E(2) receptor subtype in the rat brain: relationship to sites of interleukin-1-induced cellular responsiveness J Comp Neurol 428 2000 5 20
147. S. Saleem, Y.T. Kim, T. Maruyama, S. Narumiya, and S. Dore Reduced acute brain injury in PGE2 EP3 receptor-deficient mice after cerebral ischemia J Neuroimmunol 208 2009 87 93
148. A.S. Ahmad, M. Ahmad, A.J. de Brum-Fernandes, and S. Dore Prostaglandin EP4 receptor agonist protects against acute neurotoxicity Brain Res 1066 2005 71 77
149. J. Shi, J. Johansson, N.S. Woodling, Q. Wang, T.J. Montine, and K. Andreasson The prostaglandin E2 E-prostanoid 4 receptor exerts anti-inflammatory effects in brain innate immunity J Immunol 184 2010 7207 7218
150. T. Shiozaki, T. Hayakata, O. Tasaki, H. Hosotubo, K. Fuijita, and T. Mouri Cerebrospinal fluid concentrations of anti-inflammatory mediators in early-phase severe traumatic brain injury Shock 23 2005 406 410
151. T. Frugier, M.C. Morganti-Kossmann, D. O'Reilly, and C.A. McLean In situ detection of inflammatory mediators in post mortem human brain tissue after traumatic injury J Neurotrauma 27 2010 497 507
152. S. Homsi, F. Federico, N. Croci, B. Palmier, M. Plotkine, and C. Marchand-Leroux Minocycline effects on cerebral edema: relations with inflammatory and oxidative stress markers following traumatic brain injury in mice Brain Res 1291 2009 122 132
153. F. Clausen, A. Hanell, M. Bjork, L. Hillered, A.K. Mir, and H. Gram Neutralization of interleukin-1beta modifies the inflammatory response and improves histological and cognitive outcome following traumatic brain injury in mice Eur J Neurosci 30 2009 385 396
154. M.K. Reddy, and V. Labhasetwar Nanoparticle-mediated delivery of superoxide dismutase to the brain: an effective strategy to reduce ischemia-reperfusion injury FASEB J 23 2009 1384 1395
155. A.M. Brynskikh, Y. Zhao, R.L. Mosley, S. Li, M.D. Boska, and N.L. Klyachko Macrophage delivery of therapeutic nanozymes in a murine model of Parkinson's disease Nanomedicine (Lond) 5 2010 379 396
156. E.V. Batrakova, S. Li, A.D. Reynolds, R.L. Mosley, T.K. Bronich, and A.V. Kabanov A macrophage-nanozyme delivery system for Parkinson's disease Bioconjug Chem 18 2007 1498 1506
157. A.V. Kabanov, and H.E. Gendelman Nanomedicine in the diagnosis and therapy of neurodegenerative disorders Prog Polym Sci 32 2007 1054 1082
158. I. Sayeed, S. Parvez, B. Wali, D. Siemen, and D.G. Stein Direct inhibition of the mitochondrial permeability transition pore: a possible mechanism for better neuroprotective effects of allopregnanolone over progesterone Brain Res 1263 2009 165 173
159. I. Sayeed, and D.G. Stein Progesterone as a neuroprotective factor in traumatic and ischemic brain injury Prog Brain Res 175 2009 219 237
160. L.K. Gilmer, K.N. Roberts, and S.W. Scheff Efficacy of progesterone following a moderate unilateral cortical contusion injury J Neurotrauma 25 2008 593 602
161. D.W. Wright, A.L. Kellermann, V.S. Hertzberg, P.L. Clark, M. Frankel, and F.C. Goldstein ProTECT: a randomized clinical trial of progesterone for acute traumatic brain injury Ann Emerg Med 49 2007 391 402 402 e12.
162. G. Xiao, J. Wei, W. Yan, W. Wang, and Z. Lu Improved outcomes from the administration of progesterone for patients with acute severe traumatic brain injury: a randomized controlled trial Crit Care 12 2008 R61
163. S.W. Mitra, E. Hoskin, J. Yudkovitz, L. Pear, H.A. Wilkinson, and S. Hayashi Immunolocalization of estrogen receptor beta in the mouse brain: comparison with estrogen receptor alpha Endocrinology 144 2003 2055 2067
164. S.H. Chen, C.Y. Chang, H.K. Chang, W.C. Chen, M.T. Lin, and J.J. Wang Premarin stimulates estrogen receptor-alpha to protect against traumatic brain injury in male rats Crit Care Med 37 2009 3097 3106
165. A.J. Bruce-Keller, F.O. Dimayuga, J.L. Reed, C. Wang, R. Angers, and M.E. Wilson Gender and estrogen manipulation do not affect traumatic brain injury in mice J Neurotrauma 24 2007 203 215
166. N.D. Tran, S. Kim, H.K. Vincent, A. Rodriguez, D.R. Hinton, and M.R. Bullock Aquaporin-1-mediated cerebral edema following traumatic brain injury: effects of acidosis and corticosteroid administration J Neurosurg 112 2010 1095 1104
167. Z. Zhang, M. Artelt, M. Burnet, and H.J. Schluesener Dexamethasone attenuates early expression of three molecules associated with microglia/macrophages activation following rat traumatic brain injury Acta Neuropathol 113 2007 675 682
168. X. Chen, K.L. Zhang, S.Y. Yang, J.F. Dong, and J.N. Zhang Glucocorticoids aggravate retrograde memory deficiency associated with traumatic brain injury in rats J Neurotrauma 26 2009 253 260
169. P. Edwards, M. Arango, L. Balica, R. Cottingham, H. El-Sayed, and B. Farrell Final results of MRC CRASH, a randomised placebo-controlled trial of intravenous corticosteroid in adults with head injury-outcomes at 6 months Lancet 365 2005 1957 1959
170. S.L. Bratton, R.M. Chestnut, J. Ghajar, F.F. McConnell Hammond, O.A. Harris, and R. Hartl Guidelines for the management of severe traumatic brain injury. XV. Steroids J Neurotrauma 24 Suppl. 1 2007 S91 S95
171. X.M. Liu, L.D. Quan, J. Tian, Y. Alnouti, K. Fu, and G.M. Thiele Synthesis and evaluation of a well-defined HPMA copolymer-dexamethasone conjugate for effective treatment of rheumatoid arthritis Pharm Res 25 2008 2910 2919
172. D. Wang, S.C. Miller, X.M. Liu, B. Anderson, X.S. Wang, and S.R. Goldring Novel dexamethasone-HPMA copolymer conjugate and its potential application in treatment of rheumatoid arthritis Arthritis Res Ther 9 2007 R2
173. R. Vink, T.K. McIntosh, M.W. Weiner, and A.I. Faden Effects of traumatic brain injury on cerebral high-energy phosphates and pH: a 31P magnetic resonance spectroscopy study J Cereb Blood Flow Metab 7 1987 563 571
174. T.K. McIntosh, A.I. Faden, M.R. Bendall, and R. Vink Traumatic brain injury in the rat: alterations in brain lactate and pH as characterized by 1H and 31P nuclear magnetic resonance J Neurochem 49 1987 1530 1540
175. S. Moreno, S. Farioli-Vecchioli, and M.P. Ceru Immunolocalization of peroxisome proliferator-activated receptors and retinoid X receptors in the adult rat CNS Neuroscience 123 2004 131 145
176. J.H. Yi, S.W. Park, N. Brooks, B.T. Lang, and R. Vemuganti PPARgamma agonist rosiglitazone is neuroprotective after traumatic brain injury via anti-inflammatory and anti-oxidative mechanisms Brain Res 1244 2008 164 172
177. D. Deplanque, P. Gele, O. Petrault, I. Six, C. Furman, and M. Bouly Peroxisome proliferator-activated receptor-alpha activation as a mechanism of preventive neuroprotection induced by chronic fenofibrate treatment J Neurosci 23 2003 6264 6271
178. V.C. Besson, X.R. Chen, M. Plotkine, and C. Marchand-Verrecchia Fenofibrate, a peroxisome proliferator-activated receptor alpha agonist, exerts neuroprotective effects in traumatic brain injury Neurosci Lett 388 2005 7 12
179. X.R. Chen, V.C. Besson, B. Palmier, Y. Garcia, M. Plotkine, and C. Marchand-Leroux Neurological recovery-promoting, anti-inflammatory, and anti-oxidative effects afforded by fenofibrate, a PPAR alpha agonist, in traumatic brain injury J Neurotrauma 24 2007 1119 1131
180. J.A. Snipes, B. Kis, G.S. Shelness, J.A. Hewett, and D.W. Busija Cloning and characterization of cyclooxygenase-1b (putative cyclooxygenase-3) in rat J Pharmacol Exp Ther 313 2005 668 676
181. T. Tanabe, and N. Tohnai Cyclooxygenase isozymes and their gene structures and expression Prostaglandins Other Lipid Mediat 6869 2002 95 114
182. J.K. Gierse, J.J. McDonald, S.D. Hauser, S.H. Rangwala, C.M. Koboldt, and K. Seibert A single amino acid difference between cyclooxygenase-1 (COX-1) and -2 (COX-2) reverses the selectivity of COX-2 specific inhibitors J Biol Chem 271 1996 15810 15814
183. C.D. Breder, D. Dewitt, and R.P. Kraig Characterization of inducible cyclooxygenase in rat brain J Comp Neurol 355 1995 296 315
184. W.E. Kaufmann, P.F. Worley, J. Pegg, M. Bremer, and P. Isakson COX-2, a synaptically induced enzyme, is expressed by excitatory neurons at postsynaptic sites in rat cerebral cortex Proc Natl Acad Sci USA 93 1996 2317 2321
185. K. Yamagata, K.I. Andreasson, W.E. Kaufmann, C.A. Barnes, and P.F. Worley Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids Neuron 11 1993 371 386
186. C. Chen, J.C. Magee, and N.G. Bazan Cyclooxygenase-2 regulates prostaglandin E2 signaling in hippocampal long-term synaptic plasticity J Neurophysiol 87 2002 2851 2857
187. C. Chen, and N.G. Bazan Endogenous PGE2 regulates membrane excitability and synaptic transmission in hippocampal CA1 pyramidal neurons J Neurophysiol 93 2005 929 941
188. O. Pepicelli, E. Fedele, M. Berardi, M. Raiteri, G. Levi, and A. Greco Cyclo-oxygenase-1 and -2 differently contribute to prostaglandin E2 synthesis and lipid peroxidation after in vivo activation of N-methyl-D-aspartate receptors in rat hippocampus J Neurochem 93 2005 1561 1567
189. E. Candelario-Jalil, A. Gonzalez-Falcon, M. Garcia-Cabrera, O.S. Leon, and B.L. Fiebich Post-ischaemic treatment with the cyclooxygenase-2 inhibitor nimesulide reduces blood-brain barrier disruption and leukocyte infiltration following transient focal cerebral ischaemia in rats J Neurochem 100 2007 1108 1120
190. E. Candelario-Jalil, S. Taheri, Y. Yang, R. Sood, M. Grossetete, and E.Y. Estrada Cyclooxygenase inhibition limits blood-brain barrier disruption following intracerebral injection of tumor necrosis factor-{alpha} in the rat J Pharmacol Exp Ther 323 2007 488 498
191. C. Iadecola, K. Sugimoto, K. Niwa, K. Kazama, and M.E. Ross Increased susceptibility to ischemic brain injury in cyclooxygenase-1-deficient mice J Cereb Blood Flow Metab 21 2001 1436 1441
192. K. Chu, S.W. Jeong, K.H. Jung, S.Y. Han, S.T. Lee, and M. Kim Celecoxib induces functional recovery after intracerebral hemorrhage with reduction of brain edema and perihematomal cell death J Cereb Blood Flow Metab 24 2004 926 933
193. L. Koyfman, J. Kaplanski, A.A. Artru, D. Talmor, M. Rubin, and Y. Shapira Inhibition of cyclooxygenase 2 by nimesulide decreases prostaglandin E2 formation but does not alter brain edema or clinical recovery after closed head injury in rats J Neurosurg Anesthesiol 12 2000 44 50
194. K.I. Strauss, M.F. Barbe, R.M. Marshall, R. Raghupathi, S. Mehta, and R.K. Narayan Prolonged cyclooxygenase-2 induction in neurons and glia following traumatic brain injury in the rat J Neurotrauma 17 2000 695 711
195. T. Kunz, N. Marklund, L. Hillered, and E.H. Oliw Cyclooxygenase-2, prostaglandin synthases, and prostaglandin H2 metabolism in traumatic brain injury in the rat J Neurotrauma 19 2002 1051 1064
196. P.K. Dash, S.A. Mach, and A.N. Moore Regional expression and role of cyclooxygenase-2 following experimental traumatic brain injury J Neurotrauma 17 2000 69 81
197. I. Cernak, C. O'Connor, and R. Vink Inhibition of cyclooxygenase 2 by nimesulide improves cognitive outcome more than motor outcome following diffuse traumatic brain injury in rats Exp Brain Res 147 2002 193 199
198. J.M. Schwab, K. Seid, and H.J. Schluesener Traumatic brain injury induces prolonged accumulation of cyclooxygenase-1 expressing microglia/brain macrophages in rats J Neurotrauma 18 2001 881 890
199. R.W. Hickey, P.D. Adelson, M.J. Johnnides, D.S. Davis, Z. Yu, and M.E. Rose Cyclooxygenase-2 activity following traumatic brain injury in the developing rat Pediatr Res 62 2007 271 276
200. J.J. Gopez, H. Yue, R. Vasudevan, A.S. Malik, L.N. Fogelsanger, and S. Lewis Cyclooxygenase-2-specific inhibitor improves functional outcomes, provides neuroprotection, and reduces inflammation in a rat model of traumatic brain injury Neurosurgery 56 2005 590 604
201. T. Kunz, N. Marklund, L. Hillered, and E.H. Oliw Effects of the selective cyclooxygenase-2 inhibitor rofecoxib on cell death following traumatic brain injury in the rat Restor Neurol Neurosci 24 2006 55 63
202. M.L. Kelso, S.W. Scheff, J.R. Pauly, and C.D. Loftin Effects of genetic deficiency of cyclooxygenase-1 or cyclooxygenase-2 on functional and histological outcomes following traumatic brain injury in mice BMC Neurosci 10 2009 108
203. M. Ahmad, M.E. Rose, V. Vagni, R.P. Griffith, C.E. Dixon, and P.M. Kochanek Genetic disruption of cyclooxygenase-2 does not improve histological or behavioral outcome after traumatic brain injury in mice J Neurosci Res 86 2008 3605 3612
204. R.S. Bresalier, R.S. Sandler, H. Quan, J.A. Bolognese, B. Oxenius, and K. Horgan Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial N Engl J Med 352 2005 1092 1102
205. N.A. Nussmeier, A.A. Whelton, M.T. Brown, R.M. Langford, A. Hoeft, and J.L. Parlow Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery N Engl J Med 352 2005 1081 1091
206. F.S. Menniti, W.S. Faraci, and C.J. Schmidt Phosphodiesterases in the CNS: targets for drug development Nat Rev Drug Discov 5 2006 660 670
207. C.M. Atkins, A.A. Oliva Jr., O.F. Alonso, D.D. Pearse, H.M. Bramlett, and W.D. Dietrich Modulation of the cAMP signaling pathway after traumatic brain injury Exp Neurol 208 2007 145 158
208. C.M. Atkins, M.C. Falo, O.F. Alonso, H.M. Bramlett, and W.D. Dietrich Deficits in ERK and CREB activation in the hippocampus after traumatic brain injury Neurosci Lett 459 2009 52 56
209. R.W. Chen, A.J. Williams, Z. Liao, C. Yao, F.C. Tortella, and J.R. Dave Broad spectrum neuroprotection profile of phosphodiesterase inhibitors as related to modulation of cell-cycle elements and caspase-3 activation Neurosci Lett 418 2007 165 169
210. C.K. Donat, M.U. Schuhmann, C. Voigt, K. Nieber, R. Schliebs, and P. Brust Alterations of acetylcholinesterase activity after traumatic brain injury in rats Brain Inj 21 2007 1031 1037
211. Y. Chen, E. Shohami, S. Constantini, and M. Weinstock Rivastigmine, a brain-selective acetylcholinesterase inhibitor, ameliorates cognitive and motor deficits induced by closed-head injury in the mouse J Neurotrauma 15 1998 231 237
212. O. Tenovuo Central acetylcholinesterase inhibitors in the treatment of chronic traumatic brain injury-clinical experience in 111 patients Prog Neuropsychopharmacol Biol Psychiatry 29 2005 61 67
213. M.A. Ansari, K.N. Roberts, and S.W. Scheff Oxidative stress and modification of synaptic proteins in hippocampus after traumatic brain injury Free Radic Biol Med 45 2008 443 452
214. M.A. Ansari, K.N. Roberts, and S.W. Scheff A time course of contusion-induced oxidative stress and synaptic proteins in cortex in a rat model of TBI J Neurotrauma 25 2008 513 526
215. A. Lewen, P. Matz, and P.H. Chan Free radical pathways in CNS injury J Neurotrauma 17 2000 871 890
216. H.A. Kontos, and E.P. Wei Superoxide production in experimental brain injury J Neurosurg 64 1986 803 807
217. E.D. Hall, P.K. Andrus, and P.A. Yonkers Brain hydroxyl radical generation in acute experimental head injury J Neurochem 60 1993 588 594
218. W.O. Opii, V.N. Nukala, R. Sultana, J.D. Pandya, K.M. Day, and M.L. Merchant Proteomic identification of oxidized mitochondrial proteins following experimental traumatic brain injury J Neurotrauma 24 2007 772 789
219. Y. Deng, B.M. Thompson, X. Gao, and E.D. Hall Temporal relationship of peroxynitrite-induced oxidative damage, calpain-mediated cytoskeletal degradation and neurodegeneration after traumatic brain injury Exp Neurol 205 2007 154 165
220. L.F. Marshall, A.I. Maas, S.B. Marshall, A. Bricolo, M. Fearnside, and F. Iannotti A multicenter trial on the efficacy of using tirilazad mesylate in cases of head injury J Neurosurg 89 1998 519 525
221. B. Young, J.W. Runge, K.S. Waxman, T. Harrington, J. Wilberger, and J.P. Muizelaar Effects of pegorgotein on neurologic outcome of patients with severe head injury. A multicenter, randomized controlled trial Jama 276 1996 538 543
222. A.G. Mustafa, I.N. Singh, J. Wang, K.M. Carrico, and E.D. Hall Mitochondrial protection after traumatic brain injury by scavenging lipid peroxyl radicals J Neurochem 114 2010 271 280
223. E.D. Hall, R.A. Vaishnav, and A.G. Mustafa Antioxidant therapies for traumatic brain injury Neurotherapeutics 7 2010 51 61
224. C. Kaur, A.J. Hao, C.H. Wu, and E.A. Ling Origin of microglia Microsc Res Tech 54 2001 2 9
225. D. Davalos, J. Grutzendler, G. Yang, J.V. Kim, Y. Zuo, and S. Jung ATP mediates rapid microglial response to local brain injury in vivo Nat Neurosci 8 2005 752 758
226. A. Nimmerjahn, F. Kirchhoff, and F. Helmchen Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo Science 308 2005 1314 1318 (Pubitemid 40746128)
227. D.L. Taylor, F. Jones, E.S. Kubota, and J.M. Pocock Stimulation of microglial metabotropic glutamate receptor mGlu2 triggers tumor necrosis factor alpha-induced neurotoxicity in concert with microglial-derived Fas ligand J Neurosci 25 2005 2952 2964
228. R.D. Shytle, T. Mori, K. Townsend, M. Vendrame, N. Sun, and J. Zeng Cholinergic modulation of microglial activation by alpha 7 nicotinic receptors J Neurochem 89 2004 337 343
229. V. Papadopoulos, M. Baraldi, T.R. Guilarte, T.B. Knudsen, J.J. Lacapere, and P. Lindemann Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function Trends Pharmacol Sci 27 2006 402 409
230. S. Chen, J.D. Pickard, and N.G. Harris Time course of cellular pathology after controlled cortical impact injury Exp Neurol 182 2003 87 102
231. V.L. Raghavendra Rao, A. Dogan, K.K. Bowen, and R.J. Dempsey Traumatic brain injury leads to increased expression of peripheral-type benzodiazepine receptors, neuronal death, and activation of astrocytes and microglia in rat thalamus Exp Neurol 161 2000 102 114
232. R. Grossman, E. Shohami, A. Alexandrovich, I. Yatsiv, Y. Kloog, and A. Biegon Increase in peripheral benzodiazepine receptors and loss of glutamate NMDA receptors in a mouse model of closed head injury: a quantitative autoradiographic study Neuroimage 20 2003 1971 1981
233. H.F. Chambers Antimicrobial agents (continued): protein synthesis inhibitors and miscellaneous antibacterial agents J.G. Hardman, L.E. Limbird, A.G. Gilman, Goodman and Gilman's the pharmacological basis of therapeutics 10th ed. 2001 McGraw-Hill New York 1239 1271
234. J. Yrjanheikki, R. Keinanen, M. Pellikka, T. Hokfelt, and J. Koistinaho Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia Proc Natl Acad Sci USA 95 1998 15769 15774
235. J. Yrjanheikki, T. Tikka, R. Keinanen, G. Goldsteins, P.H. Chan, and J. Koistinaho A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window Proc Natl Acad Sci USA 96 1999 13496 13500
236. Y. Lampl, M. Boaz, R. Gilad, M. Lorberboym, R. Dabby, and A. Rapoport Minocycline treatment in acute stroke: an open-label, evaluator-blinded study Neurology 69 2007 1404 1410
237. Y.C. Weng, and J. Kriz Differential neuroprotective effects of a minocycline-based drug cocktail in transient and permanent focal cerebral ischemia Exp Neurol 204 2007 433 442
238. K. Hayakawa, K. Mishima, M. Nozako, M. Hazekawa, S. Mishima, and M. Fujioka Delayed treatment with minocycline ameliorates neurologic impairment through activated microglia expressing a high-mobility group box1-inhibiting mechanism Stroke 39 2008 951 958
239. Z. Liu, Y. Fan, S.J. Won, M. Neumann, D. Hu, and L. Zhou Chronic treatment with minocycline preserves adult new neurons and reduces functional impairment after focal cerebral ischemia Stroke 38 2007 146 152
240. N. Bye, M.D. Habgood, J.K. Callaway, N. Malakooti, A. Potter, and T. Kossmann Transient neuroprotection by minocycline following traumatic brain injury is associated with attenuated microglial activation but no changes in cell apoptosis or neutrophil infiltration Exp Neurol 204 2007 220 233
241. T.M. Tikka, and J.E. Koistinaho Minocycline provides neuroprotection against N-methyl-D-aspartate neurotoxicity by inhibiting microglia J Immunol 166 2001 7527 7533
242. T. Tikka, B.L. Fiebich, G. Goldsteins, R. Keinanen, and J. Koistinaho Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia J Neurosci 21 2001 2580 2588
243. R.O. Sanchez Mejia, V.O. Ona, M. Li, and R.M. Friedlander Minocycline reduces traumatic brain injury-mediated caspase-1 activation, tissue damage, and neurological dysfunction Neurosurgery 48 2001 1393 1399 discussion 1399401
244. S. Homsi, T. Piaggio, N. Croci, F. Noble, M. Plotkine, and C. Marchand-Leroux Blockade of acute microglial activation by minocycline promotes neuroprotection and reduces locomotor hyperactivity after closed head injury in mice: a twelve-week follow-up study J Neurotrauma 27 2010 911 921
245. J.Y. Ding, C.W. Kreipke, P. Schafer, S. Schafer, S.L. Speirs, and J.A. Rafols Synapse loss regulated by matrix metalloproteinases in traumatic brain injury is associated with hypoxia inducible factor-1alpha expression Brain Res 1268 2009 125 134
246. S.W. Scheff, and P.G. Sullivan Cyclosporin A significantly ameliorates cortical damage following experimental traumatic brain injury in rodents J Neurotrauma 16 1999 783 792
247. A.T. Mazzeo, A. Beat, A. Singh, and M.R. Bullock The role of mitochondrial transition pore, and its modulation, in traumatic brain injury and delayed neurodegeneration after TBI Exp Neurol 218 2009 363 370
248. J. Hatton, B. Rosbolt, P. Empey, R. Kryscio, and B. Young Dosing and safety of cyclosporine in patients with severe brain injury J Neurosurg 109 2008 699 707
249. P.G. Sullivan, M.B. Thompson, and S.W. Scheff Cyclosporin A attenuates acute mitochondrial dysfunction following traumatic brain injury Exp Neurol 160 1999 226 234
250. P.G. Sullivan, M. Thompson, and S.W. Scheff Continuous infusion of cyclosporin A postinjury significantly ameliorates cortical damage following traumatic brain injury Exp Neurol 161 2000 631 637
251. B.C. Albensi, P.G. Sullivan, M.B. Thompson, S.W. Scheff, and M.P. Mattson Cyclosporin ameliorates traumatic brain-injury-induced alterations of hippocampal synaptic plasticity Exp Neurol 162 2000 385 389
252. B. Alessandri, A.C. Rice, J. Levasseur, M. DeFord, R.J. Hamm, and M.R. Bullock Cyclosporin A improves brain tissue oxygen consumption and learning/memory performance after lateral fluid percussion injury in rats J Neurotrauma 19 2002 829 841
253. P. Riess, F.M. Bareyre, K.E. Saatman, J.A. Cheney, J. Lifshitz, and R. Raghupathi Effects of chronic, post-injury Cyclosporin A administration on motor and sensorimotor function following severe, experimental traumatic brain injury Restor Neurol Neurosci 18 2001 1 8
254. A.T. Mazzeo, G.M. Brophy, C.B. Gilman, O.L. Alves, J.R. Robles, and R.L. Hayes Safety and tolerability of cyclosporin a in severe traumatic brain injury patients: results from a prospective randomized trial J Neurotrauma 26 2009 2195 2206
255. L.H. Mbye, I.N. Singh, K.M. Carrico, K.E. Saatman, and E.D. Hall Comparative neuroprotective effects of cyclosporin A and NIM811, a nonimmunosuppressive cyclosporin A analog, following traumatic brain injury J Cereb Blood Flow Metab 29 2009 87 97
256. W.M. Armstead Endothelins and the role of endothelin antagonists in the management of posttraumatic vasospasm Curr Pharm Des 10 2004 2185 2192
257. B. Maier, M. Lehnert, H.L. Laurer, and I. Marzi Biphasic elevation in cerebrospinal fluid and plasma concentrations of endothelin 1 after traumatic brain injury in human patients Shock 27 2007 610 614
258. D.A. Chatfield, D.H. Brahmbhatt, T. Sharp, I.E. Perkes, J.G. Outrim, and D.K. Menon Juguloarterial Endothelin-1 Gradients After Severe Traumatic Brain Injury Neurocrit Care 2010
259. R. Salonia, P. Empey, S.M. Poloyac, S.R. Wisniewski, M. Klamerus, and H. Ozawa Endothelin-1 is increased in cerebrospinal fluid and associated with unfavorable outcomes in children after severe traumatic brain injury J Neurotrauma 27 2010 1819 1825
260. S. Kallakuri, C.W. Kreipke, P.C. Schafer, S.M. Schafer, and J.A. Rafols Brain cellular localization of endothelin receptors A and B in a rodent model of diffuse traumatic brain injury Neuroscience 168 2010 820 830
261. C.W. Kreipke, P.C. Schafer, N.F. Rossi, and J.A. Rafols Differential effects of endothelin receptor A and B antagonism on cerebral hypoperfusion following traumatic brain injury Neurol Res 32 2010 209 214
262. M. Sato, and L.J. Noble Involvement of the endothelin receptor subtype A in neuronal pathogenesis after traumatic brain injury Brain Res 809 1998 39 49
263. J.T. Cole, C.M. Mitala, S. Kundu, A. Verma, J.A. Elkind, and I. Nissim Dietary branched chain amino acids ameliorate injury-induced cognitive impairment Proc Natl Acad Sci USA 107 2010 366 371
264. M. Alkondon, E.F. Pereira, W.S. Cortes, A. Maelicke, and E.X. Albuquerque Choline is a selective agonist of alpha7 nicotinic acetylcholine receptors in the rat brain neurons Eur J Neurosci 9 1997 2734 2742
265. E.X. Albuquerque, E.F. Pereira, M.F. Braga, and M. Alkondon Contribution of nicotinic receptors to the function of synapses in the central nervous system: the action of choline as a selective agonist of alpha 7 receptors J Physiol Paris 92 1998 309 316
266. M.V. Guseva, D.M. Hopkins, S.W. Scheff, and J.R. Pauly Dietary choline supplementation improves behavioral, histological, and neurochemical outcomes in a rat model of traumatic brain injury J Neurotrauma 25 2008 975 983
267. P.G. Sullivan, J.D. Geiger, M.P. Mattson, and S.W. Scheff Dietary supplement creatine protects against traumatic brain injury Ann Neurol 48 2000 723 729
268. G. Sakellaris, M. Kotsiou, M. Tamiolaki, G. Kalostos, E. Tsapaki, and M. Spanaki Prevention of complications related to traumatic brain injury in children and adolescents with creatine administration: an open label randomized pilot study J Trauma 61 2006 322 329
269. C. Ekmekcioglu Melatonin receptors in humans: biological role and clinical relevance Biomed Pharmacother 60 2006 97 108
270. R.J. Reiter, D.X. Tan, C. Osuna, and E. Gitto Actions of melatonin in the reduction of oxidative stress. A review J Biomed Sci 7 2000 444 458
271. R.J. Reiter, R.C. Carneiro, and C.S. Oh Melatonin in relation to cellular antioxidative defense mechanisms Horm Metab Res 29 1997 363 372
272. S.M. Beni, R. Kohen, R.J. Reiter, D.X. Tan, and E. Shohami Melatonin-induced neuroprotection after closed head injury is associated with increased brain antioxidants and attenuated late-phase activation of NF-kappaB and AP-1 FASEB J 18 2004 149 151
273. B. Cirak, N. Rousan, A. Kocak, O. Palaoglu, S. Palaoglu, and K. Kilic Melatonin as a free radical scavenger in experimental head trauma Pediatr Neurosurg 31 1999 298 301
274. O. Ates, S. Cayli, I. Gurses, N. Yucel, M. Iraz, and E. Altinoz Effect of pinealectomy and melatonin replacement on morphological and biochemical recovery after traumatic brain injury Int J Dev Neurosci 24 2006 357 363
275. D.A. Hovda, A. Yoshino, T. Kawamata, Y. Katayama, and D.P. Becker Diffuse prolonged depression of cerebral oxidative metabolism following concussive brain injury in the rat: a cytochrome oxidase histochemistry study Brain Res 567 1991 1 10
276. A. Yoshino, D.A. Hovda, T. Kawamata, Y. Katayama, and D.P. Becker Dynamic changes in local cerebral glucose utilization following cerebral conclusion in rats: evidence of a hyper- and subsequent hypometabolic state Brain Res 561 1991 106 119
277. M.L. Prins, S.M. Lee, L.S. Fujima, and D.A. Hovda Increased cerebral uptake and oxidation of exogenous betaHB improves ATP following traumatic brain injury in adult rats J Neurochem 90 2004 666 672
278. L.M. Davis, J.R. Pauly, R.D. Readnower, J.M. Rho, and P.G. Sullivan Fasting is neuroprotective following traumatic brain injury J Neurosci Res 86 2008 1812 1822
279. K.S. Appelberg, D.A. Hovda, and M.L. Prins The effects of a ketogenic diet on behavioral outcome after controlled cortical impact injury in the juvenile and adult rat J Neurotrauma 26 2009 497 506
280. M.L. Prins, L.S. Fujima, and D.A. Hovda Age-dependent reduction of cortical contusion volume by ketones after traumatic brain injury J Neurosci Res 82 2005 413 420
281. R. Vink, and M.R. Bullock Traumatic brain injury: therapeutic challenges and new directions Neurotherapeutics 7 2010 1 2
282. MedWatch: The FDA Safety Information and Adverse Event Reporting Program [Internet]. Rockville, MD: U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Office of Surveillance and Epidemiology; [updated 06/23/2010; cited 06/28/2010]. http://www.fda.gov/Safety/MedWatch/default.htm
283. M. Fisher Recommendations for standards regarding preclinical neuroprotective and restorative drug development Stroke 30 1999 2752 2758
284. A.I. Faden Neuroprotection and traumatic brain injury: theoretical option or realistic proposition Curr Opin Neurol 15 2002 707 712
285. A.I. Faden Neuroprotection and traumatic brain injury: the search continues Arch Neurol 58 2001 1553 1555
286. G.Z. Feuerstein, M.M. Zaleska, M. Krams, X. Wang, M. Day, and J.L. Rutkowski Missing steps in the STAIR case: a Translational Medicine perspective on the development of NXY-059 for treatment of acute ischemic stroke J Cereb Blood Flow Metab 28 2008 217 219